1. Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation
   Si Sun et al, 2018, Cancer Science CrossRef
2. Mimicking the tumor microenvironment: Fibroblasts reduce miR-29b expression and increase the motility of ovarian cancer cells in a co-culture model
   Mariana Medeiros et al, 2019, Biochemical and Biophysical Research Communications CrossRef
3. Cancer-associated fibroblasts attenuate Cisplatin-induced apoptosis in ovarian cancer cells by promoting STAT3 signaling
   Huan Yan et al, 2016, Biochemical and Biophysical Research Communications CrossRef
4. Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistanceviaa BMP4/HH signaling loop
   Lan G. Coffman et al, 2016, Oncotarget CrossRef
5. The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
   Xiangjiao Meng et al, 2014, Radiation Oncology CrossRef
6. Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes
   Hui Sun et al, 2022, BMC Cancer CrossRef
7. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment
   Antonio Garcia-Gomez et al, 2018, Clinical Immunology CrossRef
8. Cancer epigenetics: Past, present and future
   Jae Eun Lee et al, 2022, Seminars in Cancer Biology CrossRef
9. Epigenetic regulation and therapeutic targets in the tumor microenvironment
   Zhuojun Xie et al, 2023, Molecular Biomedicine CrossRef
10. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
    Simone Brivio et al, 2015, Journal of Clinical Medicine CrossRef
11. Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
    Tiansheng Li et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
12. The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
    Tamás Barbai et al, 2015, Oncotarget CrossRef
13. Preclinical Cancer Models with the Potential to Predict Clinical Response
    Martin Scherzer et al, 2016, Drug Discovery in Cancer Epigenetics CrossRef
14. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
    Simone Brivio et al, 2017, World Journal of Hepatology CrossRef
15. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer
    Se-Ra Lee et al, 2015, Clinical Cancer Research CrossRef
16. Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?
    Marvin Sylvestre et al, 2020, Epigenomics CrossRef
17. Fibroblasts as Turned Agents in Cancer Progression
    Robert Wieder, 2023, Cancers CrossRef
18. Epigenetics in ovarian cancer: premise, properties, and perspectives
    Qilian Yang et al, 2018, Molecular Cancer CrossRef